Announced Mon, 21 Sept · 11:57 IST
Trading window closed for Q2 FY27 results at Krebs Biochemicals
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹56.53
prior close
₹57.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0-1.2——————————
Up moveDown movePending
AI summary
Krebs Biochemicals & Industries has announced closure of its trading window from close of business on September 30, 2026, until 48 hours after the declaration of unaudited financial results for Q2 and half year ending September 30, 2026. This is a routine SEBI insider trading compliance measure covering promoters, directors, designated persons and their immediate relatives. The Board meeting date to consider Q2 results will be communicated to exchanges later.
Likely market impact
Routine compliance filing indicating upcoming Q2 FY27 results announcement. No direct material impact on shareholders or stock price expected.